Perrigo Establishes Tax Base in $8.6B Elan Deal

Perrigo Establishes Tax Base in $8.6B Elan Deal Play

July 29 (Bloomberg) -- Bloomberg News' Matthew Campbell reports that Perrigo Co. has come to an agreement to buy Irish drug company Elan Corp. for $8.6 billion, establishing a low-tax base for international expansion. He speaks on Bloomberg Television's "The Pulse."

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus